1. Home
  2. EVH vs SGHT Comparison

EVH vs SGHT Comparison

Compare EVH & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolent Health Inc

EVH

Evolent Health Inc

HOLD

Current Price

$4.00

Market Cap

272.4M

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$4.97

Market Cap

235.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVH
SGHT
Founded
2011
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
272.4M
235.0M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
EVH
SGHT
Price
$4.00
$4.97
Analyst Decision
Strong Buy
Buy
Analyst Count
15
7
Target Price
$7.93
$9.08
AVG Volume (30 Days)
2.6M
329.2K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
$907,957,000.00
$77,363,000.00
Revenue This Year
$33.89
$11.67
Revenue Next Year
$15.84
$10.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$3.11
52 Week High
$11.92
$9.24

Technical Indicators

Market Signals
Indicator
EVH
SGHT
Relative Strength Index (RSI) 61.40 58.01
Support Level $3.68 $4.86
Resistance Level $4.32 $5.25
Average True Range (ATR) 0.35 0.39
MACD 0.00 0.06
Stochastic Oscillator 49.30 60.84

Price Performance

Historical Comparison
EVH
SGHT

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: